Patient groups special: Swallowing the best advice? - health - 27 October 2006 - New Scientist

Facinating article about pharmacuitical funding for patients rights groups in the US.

This is less likely to be a problem in the UK as we are too small as a market to attract the big pharmacutical companies.

Of course we may also worry that patient groups may be less likely to give information about complementary therapies if they are being funded by the pharmacutical companies.